Cellectis and AstraZeneca in US2.2bn deal - European Biotechnology News
| BAI Stock | 0.42 0.02 4.55% |
Slightly above 61% of BenevolentAI's investor base is looking to short. The analysis of current outlook of investing in BenevolentAI SA suggests that many traders are alarmed regarding BenevolentAI's prospects. BenevolentAI's investing sentiment can be driven by a variety of factors including economic data, BenevolentAI's earnings reports, geopolitical events, and overall market trends.
BenevolentAI stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BenevolentAI daily returns and investor perception about the current price of BenevolentAI SA as well as its diversification or hedging effects on your existing portfolios.
BenevolentAI |
Cellectis and AstraZeneca in US2.2bn deal European Biotechnology News
Read at news.google.com
 |
BenevolentAI Fundamental Analysis
We analyze BenevolentAI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BenevolentAI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BenevolentAI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
BenevolentAI is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
BenevolentAI SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BenevolentAI stock to make a market-neutral strategy. Peer analysis of BenevolentAI could also be used in its relative valuation, which is a method of valuing BenevolentAI by comparing valuation metrics with similar companies.
Peers
BenevolentAI Related Equities
| BAMNB | Koninklijke BAM | 5.01 | ||||
| GLPG | Galapagos | 0.78 | ||||
| PNL | PostNL NV | 1.94 | ||||
| FUR | Fugro NV | 2.24 | ||||
| AMG | AMG Advanced | 3.42 |
Additional Tools for BenevolentAI Stock Analysis
When running BenevolentAI's price analysis, check to measure BenevolentAI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BenevolentAI is operating at the current time. Most of BenevolentAI's value examination focuses on studying past and present price action to predict the probability of BenevolentAI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BenevolentAI's price. Additionally, you may evaluate how the addition of BenevolentAI to your portfolios can decrease your overall portfolio volatility.